Pfizer (NYSE:PFE) lowered its 2025 revenue forecast and issued new financial guidance for 2026, projecting modest growth outside of COVID-19 and loss-of-exclusivity products as the drugmaker works through declining pandemic demand and the impact of patent expirations.
BRP (NASDAQ:DOO) named Denis Le Vot as its next president and chief executive officer, marking a major leadership transition as José Boisjoli prepares to retire after guiding the powersports manufacturer for nearly two decades.
Tutor Perini Corp. (NYSE:TPC) won a major U.S. federal construction award that could generate up to $900 million in work over the next seven years, strengthening the contractor’s footprint in the Middle East.
Organigram Global (NASDAQ:OGI), Canada’s leading recreational cannabis producer, reported record fourth-quarter and full-year results for the period ended September 30, 2025.
Duluth Holdings (NASDAQ:DLTH) reported a significantly narrower third-quarter fiscal 2025 loss as the apparel retailer improved margins, tightened inventory, and strengthened liquidity despite a continued decline in sales.
Ford Motor (NYSE:F) will absorb a massive $19.5 billion writedown after slashing its electric vehicle (EV) strategy, scrapping long-planned investments and pulling back production in response to a steep drop in consumer demand.
Elbit Systems (NASDAQ:ESLT) said the Greek government has approved funding for the acquisition of its PULS rocket artillery system, clearing a major hurdle in a deal expected to result in a material contract for the Israeli defense company.
Cognizant (NASDAQ:CTSH), a leading global professional services company, announced today, December 16, 2025, that it has entered into a new five-year strategic agreement with ERIKS, a prominent international industrial service provider.
Apollo Global Management (NYSE:APO) has agreed to acquire a majority stake in Prosol Group, the French fresh-food retail platform best known for its Grand Frais and Fresh store networks, from private equity firm Ardian.
Bicycle Therapeutics (NASDAQ:BCYC), developer of a novel class of bicyclic peptide-based medicines, has secured a 15-year contract with the UK Nuclear Decommissioning Authority granting access to up to 400 tonnes of reprocessed uranium (RepU)—a resource the company says will underpin long-term production of lead-212 (212Pb) for its emerging cancer radioconjugate programs.
PayPal Holdings (NASDAQ:PYPL) has taken a significant step toward expanding its regulated financial-services operations, filing applications on Dec. 15, 2025 with both the Utah Department of Financial Institutions and the Federal Deposit Insurance Corporation to establish PayPal Bank, a Utah-chartered industrial loan company (ILC).
Organogenesis (NASDAQ:ORGO) has secured FDA confirmation to initiate a rolling Biologics License Application for ReNu, its knee osteoarthritis treatment, with submission set to begin before year-end 2025.
